Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00669630 · ClinicalTrials.gov registry record · NA

The GoodNEWS Lifestyle Enhancement Program

A NA study of Obesity and Hypertension, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
392
Enrollment target
1
Study location

NCT00669630 is a NA study of Obesity and Hypertension that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 392 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00669630, a NA study of Obesity and Hypertension, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
392 participants
Enrollment target
1
Study location

Study Summary

This study will train Lay Health Promoters (LHPs) from African-American churches to administer healthy living lessons and activities to their congregations in order to improve overall health and address cardiovascular disease. The primary hypothesis is that LHP training combined with a well supported maintenance strategy will be more effective than LHP training alone in reducing risk factors for cardiovascular disease.

Interventions

  • BEHAVIORAL Lay Health Promoter (LHP) with maintenance

Study Locations (1)

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 392 participants
Start Date 2008-09
Est. Completion 2012-06
Phase NA

What the Registry Record Tells You About NCT00669630

The ClinicalTrials.gov registry entry for NCT00669630 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 392 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (52% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Lay Health Promoter (LHP) with maintenance is the first listed.

NCT00669630 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00669630 about?

NCT00669630 is a clinical study titled "The GoodNEWS Lifestyle Enhancement Program". This study will train Lay Health Promoters (LHPs) from African-American churches to administer healthy living lessons and activities to their congregations in order to improve overall health and address cardiovascular disease. The primary hypothesis is that LHP training combined with a well supporte...

What is the current status of trial NCT00669630?

This trial is currently completed. It is a NA study. The enrollment target is 392 participants. The study started on 2008-09. Estimated completion is 2012-06.

What conditions does trial NCT00669630 study?

This clinical trial studies the following conditions: Obesity, Hypertension, Diabetes, Cardiovascular Disease.

What interventions are being tested in trial NCT00669630?

The interventions under investigation include: Lay Health Promoter (LHP) with maintenance (BEHAVIORAL).

Who is sponsoring clinical trial NCT00669630?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00669630 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.